Materiality
72
Source
External coverage
Decided
2026-08-04
Mixed-to-negative near-term impact: Merck raised its revenue outlook on new-drug sales but cut profit guidance due to Terns acquisition-related charges.
View event details3 more curated
Mixed-to-negative near-term impact: Merck raised its revenue outlook on new-drug sales but cut profit guidance due to Terns acquisition-related charges.
We are still collecting relevant articles for MRK. Curated events highlight the most material developments impacting this ticker right now.